Press Releases - Emmaus Medical, Inc.

Dr. Niihara Meets with Local Indian GovernorDecember 20, 2022

Cites Large, Unserved Needs of Sickle Cell Disease Patient

Dr. Niihara Feted by Indian Government in Recognition of the Development of EndariDecember 19, 2022

Emmaus Life Sciences, Inc. announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at an event held on December 16, 2022 at the World Trade Center in Mumbai, India by the Minister of State of India, Arun Halder, in recognition of Dr. Niihara’s work in developing Endari to treat sickle cell disease (SCD).

Endari Receives Kuwaiti Marketing AuthorizationDecember 07, 2022

Kuwait is Third Gulf Cooperation Council Country to Approve Endari

Emmaus Life Sciences Receives Endari Marketing Authorization from the Qatar Ministry of Public HealthNovember 17, 2022

Emmaus Life Sciences, Inc.announced today that it has been issued a Registration Certificate from the Registration Committee for Pharmaceutical Companies & their Products of the Qatar Ministry of Public Health granting marketing authorization for the commercial distribution and sale of Endari in the country.

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business UpdateNovember 14, 2022

Emmaus Life Sciences, Inc. today reported on its results of operations and financial condition as of and for the three and nine months ended September 30, 2022 and provided a business update